In vivo tumor characterization using both MR and optical contrast agents with a hybrid MRI-DOT system

Yuting Lin; Michael Ghijsen; David Thayer; Orhan Nalcioglu; Gultekin Gulsen

doi:10.1117/12.879028

10 February 2011 In vivo tumor characterization using both MR and optical contrast agents with a hybrid MRI-DOT system

Yuting Lin, Michael Ghijsen, David Thayer, Orhan Nalcioglu, Gultekin Gulsen

Proceedings Volume 7892, Multimodal Biomedical Imaging VI; 78920Z (2011) https://doi.org/10.1117/12.879028
Event: SPIE BiOS, 2011, San Francisco, California, United States

Abstract

Dynamic contrast enhanced MRI (DCE-MRI) has been proven to be the most sensitive modality in detecting breast lesions. Currently available MR contrast agent, Gd-DTPA, is a low molecular weight extracellular agent and can diffuse freely from the vascular space into interstitial space. Due to this reason, DCE-MRI has low sensitivity in differentiating benign and malignant tumors. Meanwhile, diffuse optical tomography (DOT) can be used to provide enhancement kinetics of an FDA approved optical contrast agent, ICG, which behaves like a large molecular weight optical agent due to its binding to albumin. The enhancement kinetics of ICG may have a potential to distinguish between the malignant and benign tumors and hence improve the specificity. Our group has developed a high speed hybrid MRI-DOT system. The DOT is a fully automated, MR-compatible, multi-frequency and multi-spectral imaging system. Fischer-344 rats bearing subcutaneous R3230 tumor are injected simultaneously with Gd-DTPA (0.1nmol/kg) and IC-Green (2.5mg/kg). The enhancement kinetics of both contrast agents are recorded simultaneously with this hybrid MRI-DOT system and evaluated for different tumors.

Citation Download Citation

Yuting Lin, Michael Ghijsen, David Thayer, Orhan Nalcioglu, and Gultekin Gulsen "In vivo tumor characterization using both MR and optical contrast agents with a hybrid MRI-DOT system", Proc. SPIE 7892, Multimodal Biomedical Imaging VI, 78920Z (10 February 2011); https://doi.org/10.1117/12.879028

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available

Members: $17.00

Non-members: $21.00 ADD TO CART

PROCEEDINGS
6 PAGES

DOWNLOAD PAPER SAVE TO MY LIBRARY

GET CITATION

RIGHTS & PERMISSIONS

Get copyright permission Get copyright permission on Copyright Marketplace

KEYWORDS

Tumors

Magnetic resonance imaging

Absorption

Tissues

Tissue optics

Sensors

Breast

Show All Keywords

Keywords/Phrases

Search In:

Publication Years